Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus

American Journal of Infection Control

Volumn 38, Issue 1, 2010, Pages 44-49

  Menzin, Joseph ^a   Marton, Jeno P ^b   Meyers, Juliana L ^a   Carson, Robyn T ^b   Rothermel, Constance D ^b   Friedman, Mark ^a  

^a Boston Health Economics Inc   (United States)

^b PFIZER INC   (United States)

Author keywords

antibiotics; Economics; outcomes

Indexed keywords

DAPTOMYCIN; LINEZOLID; VANCOMYCIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DATA BASE; DEMOGRAPHY; FEMALE; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SKIN AND SKIN STRUCTURE INFECTION; SKIN INFECTION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ACETAMIDES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; INPATIENTS; LENGTH OF STAY; MALE; MIDDLE AGED; OXAZOLIDINONES; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL SKIN INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN; YOUNG ADULT;

EID: 74449083807     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2009.04.287     Document Type: Article

References (16)

1. Noskin G.A., Rubin R.J., Schentag J.J., Kluytmans J., Hedblom E.C., Jacobson C., et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis 45 (2007) 1132-1140
2. Division of Healthcare Quality Promotion. National center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
3. Noskin G.A., Rubin R.J., Schentag J.J., Kluytmans J., Hedblom E.C., Smulders M., et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med 165 (2005) 1756-1761
4. Nichols R.L. Optimal treatment of complicated skin and skin structure infections. J Antimicrob Chemother 44 Suppl A (1999) 19-23
5. Martone W.J., and Nichols R.L. Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 33 Suppl 2 (2001) S67-S68
6. McCaig L.F., McDonald L.C., Mandal S., and Jernigan D.B. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis 12 (2006) 1715-1723
7. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 7 (2001) 178-182
8. Rennie R.P., Jones R.N., and Mutnick A.H. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis 45 (2003) 287-293
9. Ploy M.C., Grelaud C., Martin C., De L.L., and Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 351 (1998) 1212
10. Fung H.B., Chang J.Y., and Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs 63 (2003) 1459-1480
11. Panlilio A.L., Culver D.H., Gaynes R.P., Banerjee S., Henderson T.S., Tolson J.S., et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 13 (1992) 582-586
12. Marton J.P., Menzin J., Sussman M., Friedman M., Philburn R.T., and Rothermel C.D. The clinical and economic burden of complicated skin and skin structure infections due to Staphylococcus aureus: findings from a national database. Value Health 10 (2007) A165-A166
13. Lipsky B.A., Weigelt J.A., Gupta V., Killian A., and Peng M.M. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol 28 (2007) 1290-1298
14. Agency for Healthcare Research and Quality (AHRQ). HCUP comorbidity software v3.2. 1-31-2007. Available from: http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp#overview. Accessed July 15, 2007.
15. US Bureau of Labor Statistics, Division of Consumer Prices and Price Indexes. Consumer price indexes (CPI). 2006. Available from: http://www.bls.gov/cpi/home.htm. Accessed January 21, 2006.
16. Kopp B.J., Nix D.E., and Armstrong E.P. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother 38 (2004) 1377-1382